The Future of Positive Airway Pressure Devices….. COVID-19 & Its Impact….



The global positive airway pressure devices market size was valued at USD 1.7 billion in 2018 and is anticipated to grow at a significant rate over the forecast period. The key factor attributing to market growth is the high economic burden caused by sleep apnea. Sleep apnea is associated with numerous health problems like hypertension, heart disease, depression, and diabetes, which indirectly increases the overall economic burden on the patient. Moreover, untreated sleep apnea leads to loss of productivity at the workplace and workplace accidents caused due to the lack of sleep.
Unprecedented demand for mechanical ventilators is resulting in a significant shortage of these devices in key countries affected by the Covid-19 outbreak. The unmet demand for mechanical ventilators is forcing biomedical engineers and scientists to create makeshift ventilators using respiratory devices such as PAP, manual resuscitators, nebulizers, oxygen concentrators, and others. This is acting as a pivotal factor for the growth of PAP devices market in recent times. We at GVR are trying to quantify the impact of this pandemic on PAP devices market. Get you copy now to gain deeper insights on the same.
According to a study conducted by the American Academy of Sleep Medicine (AASM) in 2016, the annual economic burden caused due to undiagnosed sleep apnea among U.S. adults was approximately USD 149.6 billion. Whereas, treated sleep apnea would result in an annual economic savings of over USD 100 billion in the country. Due to this, the government institutions across various regions have started focusing on increasing the overall treatment rate by creating awareness among citizens on obstructive sleep apnea and its treatment, thus, boosting the demand for positive airways pressure (PAP) machines globally.
Some of the players operating in this market include Koninklijke Philips N.V. (Philips Respironics); Curative Medical; ResMed; Fisher and Paykel Healthcare Limited; Drive DeVilbiss Healthcare Inc.; and Somnetics International, Inc. These companies are focused on new product development, strategic acquisitions, and developing partnerships to gain higher market share. Moreover, strong geographic presence in multiple countries, wide product portfolio, and large number of distributors has helped the key players to strengthen their market presence.
The global positive airway pressure devices market size is anticipated to reach USD 2.7 billion by 2025, expanding at a CAGR of 7.0%, according to a new report by Grand View Research, Inc. An increase in the patient pool suffering from Obstructive Sleep Apnea (OSA) is one of the key factors anticipated to drive the market growth. Furthermore, an increase in the compliance rate of positive airways pressure (PAP) machines due to growing awareness for sleep apnea and its associated disorders is likely to drive growth over the forecast period. However, the availability of alternative treatment options such as nasal surgery, uvulopalatopharyngoplasty (UPPP), and mandibular maxillomandibular advancement surgery and the on-going clinical trials for the development of sleep apnea medications are some of the major challenges to the market growth.
Further key findings from the report suggest:
·         The global PAP Devices market is anticipated to be USD 2.7 billion by 2025, owing to the high prevalence of OSA
·         CPAP devices accounted for a major share in 2018 with a revenue of USD 1.3 billion, owing to the increasing awareness about sleep apnea related treatments among patients
·         North America dominated the market in 2018, owing to the availability of favorable reimbursement policies for PAP devices in the region
·         Some of the key players are Koninklijke Philips N.V. (Philips Respironics); Curative Medical; ResMed; Fisher and Paykel Healthcare Limited; and Drive DeVilbiss Healthcare, Inc. 
In 2018, the CPAP device dominated the market, with a revenue of USD 1.3 billion. The penetration of CPAP is increasing owing to improved patient outcomes and favorable reimbursement policies across various countries. Moreover, the launch of portable travel-friendly CPAP machines has also influenced the growth of this segment. On the other hand, the BiPAP device is expected to exhibit the fastest growth rate over the forecast period, owing to its higher efficiency compared to other PAP devices.
The positive airway pressure device manufacturers are innovating their existing product lines to achieve a better compliance rate. The competitors are focused on designing comfortable masks with more stable straps, smaller breathing masks made of soft material, and are also working on improving noise reduction features. These have helped to improve the overall efficiency of PAP machines and increase patient compliance.
Also, the rise in patient compliance rate has helped drive the market for PAP devices. Around 80% of diagnosed patients opt for PAP therapy. Most of the insurance providers grant reimbursements only when a patient adheres to the compliance standards for a stipulated amount of time in the first 90 days trial period. It helps the patients in acquiring compensation from insurance providers, which, in turn, has supported the adoption of PAP devices.
However, the high cost associated with PAP machines is likely to obstruct the positive airway pressure devices market. For instance, the average cost of a CPAP device varies between USD 1000 - USD 4000 (without insurance), depending on the brand, model of machine, and feature. Although health insurance covers the cost of sleep apnea treatment, patients are required to bear some part of the total cost. Moreover, the portable travel-friendly CPAP devices newly launched in the market, are considered merely as a luxury item and hence are not covered by any insurance coverage.
Browse Press Release of this report:
Grand View Research has segmented the global PAP devices market based on product type:
PAP Devices Product Type Outlook (Revenue, USD Million, 2014 - 2025)
·         CPAP
·         APAP
·         BiPAP
Based on product type, the global market for PAP devices is classified into CPAP, APAP, and BiPAP devices. In 2018, the CPAP devices dominated the market with a revenue of USD 1.3 billion and is anticipated to grow at a significant rate over the forecast period. CPAP is the first line of treatment for obstructive sleep apnea and has commonly prescribed to the patient who is suffering from snoring and episodes of obstructed breathing during sleep. Moreover, increased adoption of these devices due to their low cost as compared to other PAP devices has supported the growth of this segment.
About Grand View Research
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.


Comments

Popular posts from this blog

Foot Orthotic Insoles Market 2026: What Will Be Changes In Investment Ratio With Opportunity Analysis?? |Grand View Research, Inc.

A Look into Smokehouse Industry……Deep Analysis…..

A Look into Shapewear Industry……Deep Analysis…..